These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20112403)

  • 1. Excessive interleukin-1 signaling determines the development of Th1 and Th17 responses in chronic inflammation.
    Joosten LA
    Arthritis Rheum; 2010 Feb; 62(2):320-2. PubMed ID: 20112403
    [No Abstract]   [Full Text] [Related]  

  • 2. Human Th17 cells: are they different from murine Th17 cells?
    Annunziato F; Cosmi L; Liotta F; Maggi E; Romagnani S
    Eur J Immunol; 2009 Mar; 39(3):637-40. PubMed ID: 19283714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diseases that may benefit from manipulating the Th17 pathway.
    Miossec P
    Eur J Immunol; 2009 Mar; 39(3):667-9. PubMed ID: 19283719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Act1-ivating IL-17 inflammation.
    Hunter CA
    Nat Immunol; 2007 Mar; 8(3):232-4. PubMed ID: 17304231
    [No Abstract]   [Full Text] [Related]  

  • 6. TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization.
    Garlanda C; Anders HJ; Mantovani A
    Trends Immunol; 2009 Sep; 30(9):439-46. PubMed ID: 19699681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th memory for interleukin-17 expression is stable in vivo.
    Lexberg MH; Taubner A; Förster A; Albrecht I; Richter A; Kamradt T; Radbruch A; Chang HD
    Eur J Immunol; 2008 Oct; 38(10):2654-64. PubMed ID: 18825747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
    Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
    Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The link between IL-23 and Th17 cell-mediated immune pathologies.
    McGeachy MJ; Cua DJ
    Semin Immunol; 2007 Dec; 19(6):372-6. PubMed ID: 18319054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory cytokines at the summits of pathological signal cascades in brain diseases.
    Steinman L
    Sci Signal; 2013 Jan; 6(258):pe3. PubMed ID: 23322904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
    Iwakura Y; Nakae S; Saijo S; Ishigame H
    Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
    Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17 as a drug target in human disease.
    Ivanov S; Lindén A
    Trends Pharmacol Sci; 2009 Feb; 30(2):95-103. PubMed ID: 19162337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling pathogenic inflammation to fungi.
    Romani L; Puccetti P
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):1007-17. PubMed ID: 18039084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo.
    Gyülvészi G; Haak S; Becher B
    Eur J Immunol; 2009 Jul; 39(7):1864-9. PubMed ID: 19544494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell-specific deletion of gp130 renders the highly susceptible IL-10-deficient mouse resistant to intestinal nematode infection.
    Fasnacht N; Greweling MC; Bollati-Fogolín M; Schippers A; Müller W
    Eur J Immunol; 2009 Aug; 39(8):2173-83. PubMed ID: 19593768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis.
    Ciccia F; Bombardieri M; Principato A; Giardina A; Tripodo C; Porcasi R; Peralta S; Franco V; Giardina E; Craxi A; Pitzalis C; Triolo G
    Arthritis Rheum; 2009 Apr; 60(4):955-65. PubMed ID: 19333939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IL-17/IL-23 axis of inflammation in cancer: friend or foe?
    Martin-Orozco N; Dong C
    Curr Opin Investig Drugs; 2009 Jun; 10(6):543-9. PubMed ID: 19513943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.